|
⚲
|
| Foursquare Labs Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001470908 |
| Sale | 2009-08-20 ($1.4 M Offered, $1.1 M Sold) |
| Fund | |
| Phone | 9173012028 |
| Address | 36 Cooper Square, 5th Floor New York, 10003 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-09-04 (D) |
| Exemption | 506 |
| Remaining | $200,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Albert Wenger | Director | |
| Dennis Crowley | Executive Officer | |
| Naveen Selvadurai | Executive Officer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
FCP Venture X QP LLC Series IV
✚
|
0.0 | |
|
Fcreb5 LLC
✚
|
0.0 | |
|
Fcvi-E LP
✚
|
0.0 | |
|
Fcvi-Q LP
✚
|
0.0 | |
|
FDC Daisy-A LLC
✚
|
0.0 | |
|
FDC Daisy LLC
✚
|
0.0 | |
|
FDC Kindred LLC
✚
|
0.0 | |
|
FDC Peregrine III LLC
✚
|
0.0 | |
|
FDC Peregrine IV LLC
✚
|
0.0 | |
|
FCP Venture X LLC Series V
✚
|
0.0 |